Novartis offloads part of generics business in US
Swiss group in drive to focus on higher-margin innovative drugs (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - September 6, 2018 Category: Pharmaceuticals Source Type: news

EyeGate ’ s Phase 3 EGP-437 study fails to show non-inferiority
Ophthalmalogical-focused developer EyeGate Pharma said this week that the Phase 3 study of its EGP-437 delivered through its EyeGate II drug delivery system did not show non-inferiority to the prednisolone acetate ophthalmic solution control group. The Phase 3 study was evaluating the safety and efficacy of the EGP-437 with the EyeGate II in patients with non-infectious anterior segment uveitis, the Waltham, Mass.-based company said. Read the whole story on our sister site, Drug Delivery Business News The post EyeGate’s Phase 3 EGP-437 study fails to show non-inferiority appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - September 6, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Optical/Ophthalmic Pharmaceuticals Research & Development eyegatepharmaceuticals Source Type: news

Guest post: Developing new payment models to ensure patients have access to high-investment therapies
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Views represented here may not be those of PhRMA, though they are no less key to a healthy dialogue on issues in health care today. (Source: The Catalyst)
Source: The Catalyst - September 6, 2018 Category: Pharmaceuticals Authors: Guest Contributor Tags: Value-Driven Health Care The Value Collaborative Source Type: news

Will Trump's Pharma Shaming Bring Down Drug Prices? Not Likely, Poll Says
President Trump promised “voluntary massive drops in prices” from Big Pharma. Americans are skeptical. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 6, 2018 Category: Pharmaceuticals Authors: Arlene Weintraub, Contributor Tags: NYSE:PFE NASDAQ:CELG Source Type: news

Widespread Statin Use Not Recommended in Old, Very Old
THURSDAY, Sept. 6, 2018 -- Statin use is not associated with reduced risk of atherosclerotic cardiovascular disease (CVD) or all-cause mortality among older adults without type 2 diabetes, according to a study published online Sept. 5 in The... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 6, 2018 Category: Pharmaceuticals Source Type: news

Physical Activity Not Linked to Natural Early Menopause
THURSDAY, Sept. 6, 2018 -- Physical activity is not associated with natural menopause before age 45 years (early menopause), according to a study published online Aug. 21 in Human Reproduction. Mingfei Zhao, M.P.H., from the University of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 6, 2018 Category: Pharmaceuticals Source Type: news

Gaps in Prevention, Management of Tickborne Diseases Identified
THURSDAY, Sept. 6, 2018 -- Though the incidence of tickborne infections in the United States has risen significantly within the past decade, prevention and management are hampered by inadequate diagnostics as well as a lack of treatment options and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 6, 2018 Category: Pharmaceuticals Source Type: news

Psychological Distress Linked to Increased Risk of MI, Stroke
THURSDAY, Sept. 6, 2018 -- Psychological distress is associated with myocardial infarction (MI) and stroke in men and women, according to a study published online Aug. 28 in Circulation: Cardiovascular Quality and Outcomes. Caroline A. Jackson,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 6, 2018 Category: Pharmaceuticals Source Type: news

Chronic Vaping Exerts Biological Effects on Lung
THURSDAY, Sept. 6, 2018 -- Chronic vaping exerts biological effects on the lung, some of which are mediated by the propylene glycol/vegetable glycerin (PG/VG) base, according to a study published recently in the American Journal of Respiratory and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 6, 2018 Category: Pharmaceuticals Source Type: news

PSA Testing Not Recommended for Prostate Cancer Screening
THURSDAY, Sept. 6, 2018 -- Prostate cancer screening with prostate-specific antigen (PSA) testing is not recommended, although certain groups of men are more likely to undergo testing, according to a review and recommendations published online Sept.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 6, 2018 Category: Pharmaceuticals Source Type: news

Increase Observed in Hearts From Drug-Intoxicated Donors
THURSDAY, Sept. 6, 2018 -- Heart transplants using drug-intoxicated donors have significantly increased, but their use does not seem to adversely impact post-transplant survival, according to a study recently published in the American Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 6, 2018 Category: Pharmaceuticals Source Type: news

CDC Issues Recs on Diagnosis, Management of Pediatric mTBI
THURSDAY, Sept. 6, 2018 -- The U.S. Centers for Disease Control and Prevention has established an evidence-based guideline for diagnosis and management of pediatric mild traumatic brain injury (mTBI). The guideline was published online Sept. 4 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 6, 2018 Category: Pharmaceuticals Source Type: news

Perinatal Mortality Rates Remain Unchanged From 2014 to 2016
THURSDAY, Sept. 6, 2018 -- Rates of perinatal mortality remained unchanged from 2014 to 2016, according to an August data brief published by the U.S. Centers for Disease Control and Prevention's National Center for Health Statistics. Elizabeth C.W.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 6, 2018 Category: Pharmaceuticals Source Type: news

Publication Characteristics Tied to Treatment Effects
THURSDAY, Sept. 6, 2018 -- Published trials have larger treatment effects than unpublished trials, while trials published in a language other than English have larger treatment effects versus those published in English, according to research... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 6, 2018 Category: Pharmaceuticals Source Type: news

Berwyn pharma firm gets approval for ALS drug
The Food and Drug Administration has approved ITF Pharma ’s new drug application for Tiglutik, a treatment for amyotrophic lateral sclerosis or ALS. Tiglutik is, according to ITF Pharma, the first and only easy-to-swallow thickened riluzole liquid for ALS. The medicine is administered twice daily by oral syringe. ALS, also known as Lou Gehrig’s dise ase, is a progressive and ultimately fatal neurodegenerative disease marked by a gradual degeneration of nerve cells of the central nervous system… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 6, 2018 Category: Biotechnology Authors: John George Source Type: news

Pharma's Innovation Crisis, Part 1: Why The Experts Can't Fix It
Scientific excellence is the foundation of the industry, but the solution to the innovation crisis, if there is one, lies not in technology but a new business model. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 6, 2018 Category: Pharmaceuticals Authors: Standish Fleming, Contributor Source Type: news

Why Experts Can't Fix Pharma's Innovation Crisis (Part 1) And What to Do About It (Part 2)
Scientific excellence is the foundation of the industry, but the solution to the innovation crisis, if there is one, lies not in technology but a new business model. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 6, 2018 Category: Pharmaceuticals Authors: Standish Fleming, Contributor Source Type: news

Opioid Maker to Pay for Overdose-Antidote Development
A company whose prescription opioid marketing practices are being blamed for sparking the addiction and overdose crisis says it's helping to fund an effort to make a lower-cost overdose antidote. OxyContin maker Purdue Pharma announced Wednesday that it's making a $3.4 million grant to Harm Reduction Therapeutics, a Pittsburgh-based nonprofit, to help develop a low-cost naloxone nasal spray. The announcement comes as lawsuits from local governments blaming Purdue, based in Stamford, Connecticut, and other companies in the drug industry for using deceptive marketing practices to encourage heavy prescribing of the powerful a...
Source: JEMS: Journal of Emergency Medical Services News - September 6, 2018 Category: Emergency Medicine Tags: Patient Care News Source Type: news

Opioid Maker to Pay for Overdose-Antidote Development
A company whose prescription opioid marketing practices are being blamed for sparking the addiction and overdose crisis says it's helping to fund an effort to make a lower-cost overdose antidote. OxyContin maker Purdue Pharma announced Wednesday that it's making a $3.4 million grant to Harm Reduction Therapeutics, a Pittsburgh-based nonprofit, to help develop a low-cost naloxone nasal spray. The announcement comes as lawsuits from local governments blaming Purdue, based in Stamford, Connecticut, and other companies in the drug industry for using deceptive marketing practices to encourage heavy prescribing of the powerful a...
Source: JEMS Patient Care - September 6, 2018 Category: Emergency Medicine Tags: Patient Care News Source Type: news

Lawrence hospital sues state over suspended MassHealth payments
According to the lawsuit, the state stopped reimbursement because of concerns that the hospital — part of Arbour Health System — was allowing unlicensed clinicians to provide unsupervised care to patients. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 6, 2018 Category: Pharmaceuticals Authors: Jessica Bartlett Source Type: news

Catholic Health's new CEO ready to lead
With six months as CEO under his belt, Mark Sullivan is working on establishing Catholic Health as the region's quality leader. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 6, 2018 Category: Pharmaceuticals Authors: Tracey Drury Source Type: news

Novartis to divest the Sandoz US dermatology business and generic US oral solids portfolio to Aurobindo
Novartis today announced it has agreed to sell selected portions of its Sandoz US portfolio, specifically the Sandoz US dermatology business and generic US oral solids portfolio, to Aurobindo Pharma USA Inc., for USD 0.9 billion of cash plus USD 0.1 billion of potential earn-outs. (Source: World Pharma News)
Source: World Pharma News - September 6, 2018 Category: Pharmaceuticals Tags: Featured Novartis Business and Industry Source Type: news

Indian court rules criminalising homosexuality is unconstitutional
Landmark victory for the LGBT community after decades-long battle (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - September 6, 2018 Category: Pharmaceuticals Source Type: news

Roche Provides Update on Supplemental Biologics License Application (sBLA) for TECENTRIQ in First-line Metastatic Non-Squamous NSCLC
On September 05 2018, Roche was notified by the U.S. Food and Drug Administration (FDA) that the review period for the supplemental Biologics License Application (sBLA) for TECENTRIQ ® (atezolizumab) in combination with Avastin® (bevacizumab), carboplatin and paclitaxel for the initial treatment of people with metastatic non-squamous non-small cell lung cancer (NSCLC) has been extended by three months. (Source: Roche Investor Update)
Source: Roche Investor Update - September 6, 2018 Category: Pharmaceuticals Source Type: news

Roche to present new data from its extensive lung cancer programme at the 2018 World Conference on Lung Cancer (WCLC)
Roche today announced that new data from its broad clinical development programme across different types of lung cancer will be presented at the International Association for the Study of Lung Cancer (IASLC) 2018 World Conference on Lung Cancer (WCLC), taking place from 23 –26 September in Toronto, Canada. (Source: Roche Investor Update)
Source: Roche Investor Update - September 6, 2018 Category: Pharmaceuticals Source Type: news

Roche to present new data from its extensive lung cancer programme at the 2018 World Conference on Lung Cancer (WCLC)
Roche today announced that new data from its broad clinical development programme across different types of lung cancer will be presented at the International Association for the Study of Lung Cancer (IASLC) 2018 World Conference on Lung Cancer (WCLC), taking place from 23 –26 September in Toronto, Canada. (Source: Roche Media News)
Source: Roche Media News - September 6, 2018 Category: Pharmaceuticals Source Type: news

Austin to Host Inaugural National Health Equity Hackathon this October
The inaugural National Health Equity Hackathon will focus on creating data-driven solutions for underserved healthcare populations. The idea began with Health and Human Services’ Chief Data Officer,...(PRWeb September 06, 2018)Read the full story at https://www.prweb.com/releases/austin_to_host_inaugural_national_health_equity_hackathon_this_october/prweb15743465.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 6, 2018 Category: Pharmaceuticals Source Type: news

HealthyWiser ™ FemmeFresh™ Vaginal Suppository Launches on Amazon
Healthy feminine hygiene is of the utmost importance for women so FemmeFresh™ by HealthyWiser™ provides the best treatment and preventative application available.(PRWeb September 06, 2018)Read the full story at https://www.prweb.com/releases/healthywiser_femmefresh_vaginal_suppository_launches_on_amazon/prweb15743959.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 6, 2018 Category: Pharmaceuticals Source Type: news

BellBrook Labs to Exhibit New Applications for High Throughput...
BellBrook Labs will exhibit and present posters at the upcoming Discovery on Target conference in Boston, MA. At the event BellBrook will demonstrate applications for its suite of high throughput...(PRWeb September 06, 2018)Read the full story at https://www.prweb.com/releases/bellbrook_labs_to_exhibit_new_applications_for_high_throughput_screening_at_the_discovery_on_target_conference/prweb15725956.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 6, 2018 Category: Pharmaceuticals Source Type: news

Lupin to train over 1,000 graduates for pharma industry
Mumbai-headquartered Lupin has estimated that by the year 2020 they would be spending almost Rs 20 crore on this programme. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 6, 2018 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma acquires dermatology business from Sandoz in a $900 million cash deal
The acquisition will add approximately 300 products including projects in development as well as commercial and manufacturing capabilities in the US for Aurobindo. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 6, 2018 Category: Pharmaceuticals Source Type: news

This Is How Disgusting Airport Security Trays Are
A study found that these trays may be carrying more than just your bags, shoes, smartphones, and neck pillows. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 5, 2018 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

HPV Vaccine May Reduce Risk Of Transmitting Devastating Throat Disease To Children
Human papillomavirus (HPV) of the female genital tract may infect the fetus, leading to a rare, yet severe respiratory disease in infants and children. Studies are underway to address the eradication of this disease by widespread use of the HPV vaccine. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 5, 2018 Category: Pharmaceuticals Authors: Nina Shapiro, Contributor Source Type: news

06.09.18: Roadshow Frankfurt
Roadshow FrankfurtLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - September 5, 2018 Category: Pharmaceuticals Source Type: news

06.09.18: Roadshow London
Roadshow LondonLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - September 5, 2018 Category: Pharmaceuticals Source Type: news

First-ever made-in-China oncology med wins approval
The “Made in China” label may be ubiquitous on a wide array of products found in the U.S., but it hasn’t been stamped on many cancer drugs — at least, not until now. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 5, 2018 Category: Pharmaceuticals Source Type: news

Experimental treatment shows promise in treating rare form of blindness
Dutch drugmaker ProQR Therapeutics has reported promising results from an early stage trial targeting children with a rare form of blindness. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 5, 2018 Category: Pharmaceuticals Source Type: news

A DSCSA Checklist — Are You Ready?
The DSCSA enforcement is fast-approaching and the pressure is on pharmaceutical manufacturers and distributors to adapt their processes. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 5, 2018 Category: Pharmaceuticals Source Type: news

Sick Passengers On Flight From Dubai: Key Facts About Illness On Airplanes
Several passengers became acutely ill on a flight from Dubai to New York City. Here's what you need to know about illnesses while flying. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 5, 2018 Category: Pharmaceuticals Authors: Lipi Roy, Contributor Source Type: news

CDC: Why You Should Not Eat Any Kellogg's Honey Smacks Cereal
The CDC has just upped its warning about the cereal. So far, the ongoing multi-state Salmonella Mbandaka outbreak has affected at least 130 people in 36 states. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 5, 2018 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

Heart CTA Results in Lower Death Rate From CHD, Non-Fatal MI
WEDNESDAY, Sept. 5, 2018 -- For patients with stable chest pain, coronary computed tomographic angiography (CTA) results in a lower rate of death from coronary heart disease or non-fatal myocardial infarction at five years, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 5, 2018 Category: Pharmaceuticals Source Type: news

Baloxavir Superior to Placebo for Alleviating Flu Symptoms
WEDNESDAY, Sept. 5, 2018 -- The selective inhibitor of influenza cap-dependent endonuclease, baloxavir marboxil, is superior to placebo for alleviating influenza symptoms, according to a study published in the Sept. 6 issue of the New England... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 5, 2018 Category: Pharmaceuticals Source Type: news

Google Search for Cardiovascular Disease Peaks in Winter
WEDNESDAY, Sept. 5, 2018 -- Google search query volumes related to cardiovascular disease (CVD) follow a strong seasonal pattern, according to a study published in the September issue of the Mayo Clinic Proceedings. Nilay Kumar, M.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 5, 2018 Category: Pharmaceuticals Source Type: news

130 Now Sickened by Salmonella-Tainted Honey Smacks Cereal
WEDNESDAY, Sept. 5, 2018 -- One hundred thirty people across 36 states have now fallen ill with Salmonella after eating Kellogg's Honey Smacks cereal, according to the U.S. Centers for Disease Control and Prevention. Many of the illnesses linked to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 5, 2018 Category: Pharmaceuticals Source Type: news

Recent Increase in Contraception Use Noted Among U.S. Teenagers
WEDNESDAY, Sept. 5, 2018 -- Among U.S. adolescents, there were increases in contraceptive use from 2007 to 2014, including dual-method use and long-acting reversible contraception, according to a study published in the August issue of the Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 5, 2018 Category: Pharmaceuticals Source Type: news

Senate Bill Would Legalize Medical Marijuana For Military Veterans
Military veterans would be able to legally access and use medical cannabis under a new Senate bill. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 5, 2018 Category: Pharmaceuticals Authors: Tom Angell, Contributor Source Type: news

As Theranos Dissolves, Healthcare Startup Funding Hits Record High
Venture capital funding for healthcare startups this year hit $20 billion in August. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 5, 2018 Category: Pharmaceuticals Authors: Michela Tindera, Forbes Staff Source Type: news

England's Health Service Does Deal With Novartis To Provide Kymriah For Relapsed Childhood Leukemia
The National Health Service in England will offer CAR T-cell therapy to children with leukemia after striking a discount deal with Novartis. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 5, 2018 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Tags: NASDAQ:NVS Source Type: news

Theranos: chasing waterfalls
The upcoming fights between unicorn investors will be brutal (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - September 5, 2018 Category: Pharmaceuticals Source Type: news

Calorie labelling on menus too ‘burdensome’
Minister says anti-obesity measure could cause higher food prices and job losses (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - September 5, 2018 Category: Pharmaceuticals Source Type: news